Project description DEENESFRITPL Better drug accessibility through innovative cell-based manufacture Delivering life-saving medication fast and effectively is challenging from an engineering and manufacturing aspect. The II-LCA project changes manufacturing at cell level to make medicine more accessible. The project will fund the recruitment of an innovation associate in the Valitacell company, enhancing its capabilities in cell imaging, life sciences instrumentation and automation, and boosting the creation of new drugs and cellular therapeutics. The reduced cost of and improvement in manufacture will benefit a larger population in Europe, who will also have direct access to new therapies. Show the project objective Hide the project objective Objective The successful recruitment and incorporation of an Innovation associate (IA), with expertise in live cell imaging, life sciences instrumentation and automation, into the Valitacell team is integral to the evolution of our technologies. The IA will dramatically enhance Valitacells capabilities in this space, strengthen existing collaborations, and generate further opportunities for future innovation. If successful, II-LCA will lead to the accelerated development of novel biological drugs and cellular therapeutics, for the treatment of diverse disease indications. European patients will benefit from increased access to targeted and innovative breakthrough therapies, through reduced cost of development and improved manufacturing paradigms. Fields of science social sciencessociologyindustrial relationsautomationmedical and health sciencesmedical biotechnologycells technologies Programme(s) H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme H2020-EU.2.3.2.2. - Enhancing the innovation capacity of SMEs Topic(s) INNOSUP-02-2019-2020 - European SME innovation Associate - pilot Call for proposal H2020-INNOSUP-2018-2020 See other projects for this call Sub call H2020-INNOSUP-2019-02 Funding Scheme CSA - Coordination and support action Coordinator VALITACELL LTD Net EU contribution € 123 746,25 Address Fosters ave. - mount merrion, blackrock V94 Dublin 2 Ireland See on map Region Ireland Eastern and Midland Dublin Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Other funding € 0,00
